Prostate Cancer and Sex
Everyone reacts differently to having cancer both physically and emotionally. Many men do not feel like sex during, before and after their treatment for prostate cancer. The majority of people feel very 'low' once they have been given a cancer diagnosis and feeling like this is not going to help their sex life. On the other hand, some men have an opposite reaction to their diagnosis by feeling that they should be living life to the full and enjoying their sex life to the utmost. Neither is wrong; it's just how different men cope in their own particular way. Whichever way, this disruption to a man's sexual relationship will be difficult to tolerate. Any man who is suffering with prostate cancer should always try to remember that with time, things should change and they will not know how they will be permanently affected until their treatment has finished and things are getting back to normal. It's pointless to contemplate a sexual future until all options have been considered and treatment has been completed.
Most side effects from the treatment of prostate cancer are only temporary. For example, the fatigue and diarrhoea which is a side effect of radiotherapy usually begins to wear off in the weeks following the end of a person's treatment. The effects of this treatment can be wearying, however if it can be tolerated the effects do wear off after the treatment has been completed.
If a man is less interested in sex, it can be due to a number of reasons. These include the effects of an Orchidectomy or hormone treatment. A lowered interest in sex cannot be treated like it usually would be by the use of testosterone injections or patches. This would be counter productive due to some treatments for the prostate cancer being female hormone based. Giving a man the male hormone testosterone would accelerate the growth of the tumor and would negate the effects of the treatment being given. Changing the treatment itself may be a benefit as a lack of sexual interest is less likely with anti-androgens such as bicalutamide. Therefore any man undergoing treatment should consider discussing their options with their health specialist.
Side effects such as these may be very difficult to live with and how a man looked upon his sex life before diagnosis will play a major role. Whether or not a man has a partner will also determine how he takes to the changes in his sex life. It is very important that issues such as these are discussed between partners so enable you both to come to terms with the major changes you will face. Its important to remember that a diagnosis of prostate cancer affects a man's partner as well as himself.
Symptoms which might be a side effect of orchidectomy or hormone therapy may include hot flushes and sweats. These symptoms are usually at their worst when a man has just bean hormone treatment or had their testicles removed, although they can get better as the body adjusts.
Prostate cancer news on the Web
The Impact Of Urologic Diseases On The American Public Urologic conditions like urinary tract infections, kidney stones, and prostate cancer are a major economic burden on Americans, resulting in health care costs of close to $40 billion annually, according to a newly released national report that charts the demographic and economic impact of urologic diseases in the U.S... |
Distinct Molecular Subtype Of Prostate Cancer Discovered A collaborative expedition into the deep genetics of prostate cancer has uncovered a distinct subtype of the disease, one that appears to account for up to 15 percent of all cases, say researchers at Weill Cornell Medical College, the Broad Institute of MIT and Harvard and the Dana-Farber Cancer Institute... |
Hormone-Depleting Drug Shows Promise Against Localized High-Risk Prostate Tumors A hormone-depleting drug approved last year for the treatment of metastatic prostate cancer can help eliminate or nearly eliminate tumors in many patients with aggressive cancers that have yet to spread beyond the prostate, according to a clinical study to be presented at the annual meeting of the American Society of Clinical Oncology (ASCO), June 1-5, in Chicago... |
Racial Disparities Revealed In Prostate Cancer Surgery Black prostate cancer patients may not be getting the same quality of care as white patients, according to a first-of-its-kind study by researchers at Henry Ford Hospital who found racial disparities in the results of surgery to remove diseased prostates... |
Avoiding Repeat Biopsies In Prostate Cancer - MDxHealth Launches ConfirmMDx Each year, in the United States, more than 650,000 men receive a negative prostate biopsy result, with around 25-35% of these results being false negative. However, a new prostate cancer test has been launched by MdxHealth. The test - ConfirmMDx™ for Prostate Cancer - will help physicians identify which men have a true-negative prostate biopsy from those who may have occult cancer... |
Ancient Remedy Slows Prostate Tumor Cell Proliferation An over-the-counter natural remedy derived from honeybee hives arrests the growth of prostate cancer cells and tumors in mice, according to a new paper from researchers at the University of Chicago Medicine. Caffeic acid phenethyl ester, or CAPE, is a compound isolated from honeybee hive propolis, the resin used by bees to patch up holes in hives... |
Prostate Cancer Stem Cells Identified Among Low-PSA Cells Prostate cancer cells that defy treatment and display heightened tumor-generating capacity can be identified by levels of prostate specific antigen (PSA) expressed in the tumor cells, a research team led by scientists at The University of Texas MD Anderson Cancer Center reports in Cell Stem Cell... |
Gay Men And Minorities Have Poorer Quality Of Life After Prostate Cancer Treatment To improve the quality of life in gay men and minorities treated for prostate cancer, a greater awareness of ethnic and sexual preference-related factors is needed to help men choose a more-suitable treatment plan, researchers from Thomas Jefferson University Hospital conclude in a literature review published in Nature Reviews Urology... |
Boron-Nitride Nanotubes Show Potential In Cancer Treatment A new study has shown that adding boron-nitride nanotubes to the surface of cancer cells can double the effectiveness of Irreversible Electroporation, a minimally invasive treatment for soft tissue tumors in the liver, lung, prostate, head and neck, kidney and pancreas. Although this research is in the very early stages, it could one day lead to better therapies for cancer... |
Denosumab (Xgeva) Not Approved For Metastasis Prevention Amgen's application for expanded indications for denosumab (Xgeva) were turned down by the FDA (Food and Drug Administration) - the expanded indications were to include bone metastases prevention in patients with castration-resistant prostate cancer... |
Prostate Cancer Cells Destroyed By The Common Herb Oregano Oregano, the common pizza and pasta seasoning herb, has long been known to possess a variety of beneficial health effects, but a new study by researchers at Long Island University (LIU) indicates that an ingredient of this spice could potentially be used to treat prostate cancer, the second leading cause of cancer death in American men... |
Males With Mutated BRCA1 Breast Cancer Gene Have Higher Prostate Cancer Risk Men who carry the mutated BRCA1 gene have a four times greater chance of developing prostate cancer than other males, researchers from the Institute of Cancer Research and the Royal Marsden NHS Foundation Trust reported in the British Cancer Journal. The mutated BRCA1 is found in people with a family history of not only breast cancer, but ovarian cancer as well... |
Prostate Cancer And Radiation Therapies - The Need For Additional Treatments In the April 18 issue of JAMA, a study comparing traditional radiation therapy to treat localized prostate cancer with intensity-modulated radiation therapy (IMRT) and proton therapy reveals thats IMRT was linked to fewer gastrointestinal side effects, receipt of additional cancer treatments and hip fractures but to more erectile dysfunction, whilst those who received proton ... |
|